Planning and Implementation Screening for Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome: A Family Affair

This session was held on December 15, 2020.
​The objectives were:
  • Define Neonatal Abstinence Syndrome (NAS)/Neonatal Opioid Withdrawal Syndrome (NOWS);
  • Describe the rationale for medical management of NAS/NOWS;
  • Describe the impact of social determinants on infant developmental outcomes.
Funding for this website and programs were made possible (in part) by (Substance  Abuse Prevention & Treatment Block Grant B08TI010057-19 funding.) from SAMHSA.

The views expressed in this website and materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. ​